{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:05:12Z","timestamp":1791108312484,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,27]]},"DOI":"10.1097\/tp.0b013e318298dd65","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T13:52:58Z","timestamp":1373377978000},"page":"413-420","source":"Crossref","is-referenced-by-count":70,"title":["Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection"],"prefix":"10.1097","volume":"96","author":[{"given":"Gemma","family":"Banham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Prezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Harford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menna R.","family":"Clatworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-13-20210129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrneph.2010.111","article-title":"B cells and transplantation tolerance.","volume":"6","author":"Kirk","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R3-13-20210129","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1600-6143.2011.03554.x","article-title":"Targeting B cells and antibody in transplantation.","volume":"11","author":"Clatworthy","year":"2011","journal-title":"Am J Transplant"},{"key":"R4-13-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.immunol.21.120601.141152","article-title":"BAFF AND APRIL: a tutorial on B cell survival.","volume":"21","author":"Mackay","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V97.1.198","article-title":"Synthesis and release of B-lymphocyte stimulator from myeloid cells.","volume":"97","author":"Nardelli","year":"2001","journal-title":"Blood"},{"key":"R6-13-20210129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.smim.2006.04.005","article-title":"The role of the BAFFAPRIL system on T cell function.","volume":"18","author":"Mackay","year":"2006","journal-title":"Semin Immunol"},{"key":"R7-13-20210129","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1002\/eji.200425198","article-title":"BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.","volume":"34","author":"Ye","year":"2004","journal-title":"Eur J Immunol"},{"key":"R8-13-20210129","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.20062567","article-title":"BAFF and MyD88 signals promote a lupuslike disease independent of T cells.","volume":"204","author":"Groom","year":"2007","journal-title":"J Exp Med"},{"key":"R9-13-20210129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases.","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R10-13-20210129","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar2773","article-title":"Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort.","volume":"11","author":"Gottenberg","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R11-13-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2141.2006.06431.x","article-title":"High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.","volume":"136","author":"Emmerich","year":"2007","journal-title":"Br J Haematol"},{"key":"R12-13-20210129","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/TP.0b013e318246621d","article-title":"Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLySBAFF.","volume":"93","author":"Parsons","year":"2012","journal-title":"Transplantation"},{"key":"R13-13-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.transproceed.2008.10.037","article-title":"The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection.","volume":"41","author":"Xu","year":"2009","journal-title":"Transplant Proc"},{"key":"R14-13-20210129","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.transproceed.2008.10.024","article-title":"Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients.","volume":"41","author":"Xu","year":"2009","journal-title":"Transplant Proc"},{"key":"R15-13-20210129","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/TP.0b013e3181735723","article-title":"B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.","volume":"85","author":"Thaunat","year":"2008","journal-title":"Transplantation"},{"key":"R16-13-20210129","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/j.1600-6143.2012.04194.x","article-title":"BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies.","volume":"12","author":"Thibault-Espitia","year":"2012","journal-title":"Am J Transplant"},{"key":"R17-13-20210129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"R18-13-20210129","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/TP.0b013e3181bbba1a","article-title":"BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection.","volume":"88","author":"Zarkhin","year":"2009","journal-title":"Transplantation"},{"key":"R19-13-20210129","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1600-6143.2009.02710.x","article-title":"BAFF is increased in renal transplant patients following treatment with alemtuzumab.","volume":"9","author":"Bloom","year":"2009","journal-title":"Am J Transplant"},{"key":"R20-13-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10875-009-9327-3","article-title":"B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis.","volume":"30","author":"Thompson","year":"2010","journal-title":"J Clin Immunol"},{"key":"R21-13-20210129","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/rheumatology\/ker282","article-title":"Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.","volume":"50","author":"Eilertsen","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R22-13-20210129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.gene.6363923","article-title":"Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis.","volume":"3","author":"Kawasaki","year":"2002","journal-title":"Genes Immun"},{"key":"R23-13-20210129","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.2005.02.7938","article-title":"Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.","volume":"24","author":"Novak","year":"2006","journal-title":"J Clin Oncol"},{"key":"R24-13-20210129","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1884","article-title":"No evidence for an association between the -871 TC promoter polymorphism in the B-cell-activating factor gene and primary Sjogrens syndrome.","volume":"8","author":"Gottenberg","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R25-13-20210129","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ndt\/15.4.502","article-title":"B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2.","volume":"15","author":"Fernandez-Fresnedo","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R26-13-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ndt\/gfp397","article-title":"Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.","volume":"25","author":"Pahl","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R27-13-20210129","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2007-09-110858","article-title":"APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.","volume":"111","author":"Belnoue","year":"2008","journal-title":"Blood"},{"key":"R28-13-20210129","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1172\/JCI18025","article-title":"BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.","volume":"112","author":"Avery","year":"2003","journal-title":"J Clin Invest"},{"key":"R29-13-20210129","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar3738","article-title":"Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial.","volume":"14","author":"Ginzler","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R30-13-20210129","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0b013e31822dc38d","article-title":"Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.","volume":"92","author":"Higgins","year":"2011","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e318298dd65","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:33:39Z","timestamp":1620977619000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201308270-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,27]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318298dd65","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,27]]}}}